No Data
No Data
CVC Completes Acquisition of Therakos From Mallinckrodt
Express News | Mallinckrodt Completes Divestiture of Therakos® Business
Mallinckrodt Presents Data on TERLIVAZ (Terlipressin) for Injection in Patients With Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Mallinckrodt to Present at Jefferies London Healthcare Conference
Mallinckrodt Announces the 2024 Winner of the Extracorporeal Immunomodulation Award
10-Q: Q3 2024 Earnings Report
Lnova : thanks for sharing
Lnova : $0.12 stock wow
Jaguar8 OP Lnova : This is in OTC
Lnova Jaguar8 OP : ah, gotcha. Ty